Pamela Klein
Hematology & Oncology · San Francisco, CANPI 1851254171
Payments from drug & device makers
$509,601in general payments, 2019–2025
Across 60 payments — averaging $8493.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$510K
What the payments were for
- Consulting fees$398,72178%
- Speaking & faculty fees$82,98216%
- Travel & lodging$25,5775%
- Food & beverage$2,3220%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Argenx US, Inc. | 60 | $509,601 |
How this compares
$509,601 in reported general payments places this provider in the 85th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in San Francisco
- Alain AlgaziSan Francisco$119.2M
- Pamela MunsterSan Francisco$13.7M
- Collin BlakelySan Francisco$8.8M
- Terence FriedlanderSan Francisco$3.8M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Joseph TuscanoSacramento$20.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.